News & Updates
Showing Oncology articles
Showing
Ixazomib dexamethasone a new treatment in the arsenal against RRMM
In heavily pretreated, lenalidomide-refractory patients with relapsed-refractory multiple myeloma (RRMM) and prior exposure to proteasome inhibitors, ixazomib dexamethasone may be an effective and tolerable treatment approach, leading to comparable health-related quality of life outcomes as pomalidomide-dexamethasone, a recent study has found.
Patient-reported outcomes tied to healthcare use in NDMM
Patient-reported outcome measures may help predict healthcare utilization, such as emergency department visits or unplanned hospitalizations, among patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM), a recent study has found.
Trastuzumab biosimilar on par with reference agent in HER2-positive gastric cancer
CT-P6, a trastuzumab biosimilar approved for the treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC), is as efficacious as reference trastuzumab in terms of response rates, progression-free (PFS) and overall survival (OS), a study has shown.
FOLFIRINOX safe, effective in older adults with advanced pancreatic cancer
The combination therapy of 5-fluorouracil, irinotecan, leucovorin, and oxaliplatin (FOLFIRINOX) improves response and overall survival (OS) in older adults with advanced pancreatic cancer (APC), a recent study has shown.
East Asia tops global lung cancer incidence and mortality
East Asia topped the world’s incidence and mortality of lung cancer in 2020, according to a global study conducted by the Chinese University of Hong Kong (CUHK) and the Association of Pacific Rim Universities (APRU).
